Acquire Approval to Begin Working With Controlled Substances (DAF/DCM)
A clinical practice DEA license cannot be used to obtain controlled substances for a research program. Washington University, in accordance with the laws of the State of Missouri and the regulations of the Missouri Bureau of Narcotics & Dangerous Drugs (BNDD), require that an individual maintain separate registrations for their research and clinical programs. You […]
Define “Access to Controlled Substances”
Anyone who is responsible for obtaining, assuring secure storage, managing the initial or annual inventory, completing the aliquot logs, record keeping, distributing controlled substances or a dilution thereof to other approved laboratory personnel, dispensing to an animal or disposing.
Close a Stem Cell Project
February 10, 2017 Send an email to ORIE@wustl.edu referencing the project number Indicate the reason for the closure. For example: No longer using hESCs Lost funding Project completed Leaving Washington University Describe your plans for the hESCs: Destruction Transfer to another Washington University investigator Take to new institution ESCRO will review the terms of the […]
Determine if an MTA is Needed for Stem Cells
February 10, 2017 A Materials Transfer Agreement (MTA) is required for both incoming and outgoing materials. A MTA typically is required when human embryonic stem cells (hESC) are received or shared between Washington University investigators and other academic or industry partners. An MTA or approval/authorization also may be required to obtain hESCs from the WU […]
Submit Stem Cell Project Amendment
February 10, 2017 Complete the ESCRO Amendment (DOC) and email to ORIE@wustl.edu. ESCRO approval covers only the research and specific use of hESC/hPSC/hiPSC lines described in your approved ESCRO application. Any change in the research or hES cell lines approved by ESCRO must be submitted as an Amendment and approved by ESCRO before making the change. […]
Submit Stem Cell Project Annual Renewal
February 10, 2017 ESCRO approval is required annually. You will receive a reminder email approximately six weeks before your expiration date. To continue approval of your ESCRO project: Complete the Renewal Form (DOC) Have the form signed by your department chair Email all documents to ORIE@wustl.edu
Determine Who Can be a PI on an ESCRO Project
February 10, 2017 PIs are usually Washington University faculty members with appointments of instructor or above. However, postdocs who receive their own funding for research using hESC/hPSC (e.g., fellowship award, internal seed grant) will be the PI on the ESCRO application. The research must be overseen by a faculty member, usually the mentor on the […]
Submit New Stem Cell Project Application
February 10, 2017 Complete the ESCRO Application [DOC]. Attach research plan (required) For department funded research, attach a description of research significance and background, experimental design, and potential outcomes (see ESCRO Research Plan Template [DOC]). For sponsored research, attach awarded grant application(s) that supports this research. If proposing to generate new hESC lines or use hESCs […]
Determine if ESCRO Approval is Needed
February 10, 2017 ESCRO review and approval is needed when any of the following biological materials are used for research purposes: Human embryonic stem cells (hESC) Materials derived from a human embryo, including hESC-derived neural progenitors and other hESC derivatives Other human pluripotent stem cells, including human induced pluripotent stem cells (hiPSC) or their derivatives […]